Abstract-Obstructive sleep apnea occurs frequently in patients with drug-resistant hypertension. The factors accounting for this observation, however, are unclear. Both conditions demonstrate clinical features suggestive of extracellular fluid volume overload. The aims of this study were to examine whether the spontaneous overnight fluid shift from the legs to the upper body is associated with obstructive sleep apnea in hypertensive subjects and whether its magnitude is greater in drug-resistant hypertension. Leg fluid volume and the circumference of the calf and neck were measured before and after sleep in drug-resistant hypertensive (nϭ25) and controlled hypertensive (nϭ15) subjects undergoing overnight polysomnography. The severity of obstructive sleep apnea was greater in the drug-resistant hypertensive group than in the controlled hypertensive group (apnea-hypopnea index: 43.0Ϯ5.4 versus 18.1Ϯ4.2 events per hour of sleep; Pϭ0.02, case-mix adjusted). In both groups, the apnea-hypopnea index strongly related to the amount of leg fluid volume displaced (R 2 ϭ0.56; PϽ0.0001), although the magnitude of change was greater in the drug-resistant hypertensive group (346.7Ϯ24.1 versus 175.8Ϯ31.3 mL; Pϭ0.01, propensity-score adjusted). The overnight reduction in calf circumference and increase in neck circumference were also greater in drug-resistant hypertension (both PՅ0.02). In hypertensive subjects, rostral fluid displacement strongly relates to the severity of obstructive sleep apnea with its magnitude being greater in drug-resistant hypertension. Our findings support the concept that fluid redistribution centrally during sleep accounts for the high prevalence of obstructive sleep apnea in drug-resistant hypertension. rug-resistant hypertension (DRH) is emerging as a major and growing problem in managing hypertension. It accelerates the atherosclerotic burden of aging and is associated with a significant increased risk of hypertensive target organ damage. 1 In a previous study, we reported that patients with DRH had a very high prevalence of obstructive sleep apnea (OSA) 2 and subsequently demonstrated that treatment of OSA with continuous positive airway pressure was accompanied by a significant fall in both nighttime and daytime blood pressure (BP). 3 Obesity is associated both with decreased responsiveness to antihypertensive medications 4 and with OSA. 5 Whether obesity is the factor that explains the association between DRH and OSA, however, is unclear, because increased body weight and neck girth only account for approximately one third of the variability in the frequency of apneas and hypopneas per hour of sleep (ie, the apneahypopnea index [AHI]). 6 Moreover, the factors accounting for weight-related antihypertensive drug resistance have not been identified.
D rug-resistant hypertension (DRH) is emerging as a major and growing problem in managing hypertension. It accelerates the atherosclerotic burden of aging and is associated with a significant increased risk of hypertensive target organ damage. 1 In a previous study, we reported that patients with DRH had a very high prevalence of obstructive sleep apnea (OSA) 2 and subsequently demonstrated that treatment of OSA with continuous positive airway pressure was accompanied by a significant fall in both nighttime and daytime blood pressure (BP). 3 Obesity is associated both with decreased responsiveness to antihypertensive medications 4 and with OSA. 5 Whether obesity is the factor that explains the association between DRH and OSA, however, is unclear, because increased body weight and neck girth only account for approximately one third of the variability in the frequency of apneas and hypopneas per hour of sleep (ie, the apneahypopnea index [AHI] ). 6 Moreover, the factors accounting for weight-related antihypertensive drug resistance have not been identified.
Many studies have demonstrated abnormalities in extracellular fluid volume regulation in DRH and OSA. Plasma renin is generally suppressed in both conditions, 7, 8 and primary aldosteronism is a common finding in DRH. 9 BP of DRH patients often falls dramatically with the administration of mineralocorticoid antagonists and other diuretics 10, 11 or consumption of a low-salt diet. 12 Studies in dialysis patients revealed marked improvement in sleep apnea with dialytic treatments that more efficiently remove fluid. 13, 14 The possibility that extracellular fluid volume expansion is the common factor linking OSA with DRH was suggested recently in a study demonstrating that spironolactone reduces the severity of OSA in patients with DRH. 15 Although volume overload is considered to be an important feature of DRH and OSA, less attention has been paid in determining the location of the excess fluid and the impact of changes on its distribution during sleep. It is well established that, during sitting or standing, there is an increase in extracellular fluid in the lower parts of the body as a consequence of gravitational forces and a reduction in intravascular volume. During recumbency, there is a rapid increase in intravascular volume and a decrease in interstitial fluid volume, 16 and the changes are detectable within 15 minutes using current measurement tools. 17 From initial studies carried out in our laboratory, 18 -20 we posited that, during sleep, redistribution of intravascular fluid from the legs to the chest and neck would predispose patients with fluid overload to OSA because of increased nuchal and peripharyngeal edema that would compress the upper airway and obstruct airflow.
The present study was undertaken to determine whether the high prevalence of OSA in DRH might be related to an exaggerated overnight rostral fluid shift. We hypothesized that the severity of OSA is directly related to the amount of fluid displaced from the legs overnight and that, compared with patients with controlled hypertension (CH), the degree of overnight rostral fluid displacement will be greater in DRH subjects.
Methods

Subjects
Patients with CH and DRH were recruited from the hypertension clinic at the Mount Sinai Hospital. DRH was defined as a clinic BP Ն140/90 or Ն130/80 mm Hg in patients with diabetes mellitus or stage 3 to 5 chronic kidney disease at Ն2 office visits Ն4 weeks apart while adherent to Ն3 antihypertensive medications at maximal or near-maximal doses including a diuretic, unless contraindicated or intolerant, or as a BP below these levels while on Ն4 antihypertensive medications. 21 CH was defined as a clinic BP Ͻ140/90 or Ͻ130/80 mm Hg in patients with diabetes mellitus or stage 3 to 5 chronic kidney disease on Ն2 consecutive occasions while on Յ3 antihypertensive medications. BP was also measured by 24-hour ambulatory BP monitoring using SpaceLabs monitor (SL-90207, SpaceLabs Medical) in patients with suspected white-coat effect, following our regular clinic protocol. 22 Patients were excluded if they were nonadherent to prescribed drug treatment (self-report), had a correctable secondary form of hypertension, ingested exogenous substances (including alcohol) that can raise BP (current or in previous 2 weeks), had symptomatic heart failure with a left ventricular ejection fraction Ͻ50%, or were symptomatic from coronary artery disease requiring nitrates. 23 Otherwise, if applicable, nitrates and phosphodiesterase-5 inhibitors 24 were withheld for 2 weeks before study enrollment.
The following sociodemographic, anthropometric, and clinical variables were collected on each patient: age, sex, race, diabetic status, cardiovascular disease, body mass index (BMI), weekly physical activity, and class and number of antihypertensive drug(s). In determining number of antihypertensive medications, dihydropyridine and nondihydropyridine calcium channel blockers were considered as 2 separate drugs, as were diuretics with actions on different nephron sites. 2D echocardiography was used to detect left ventricular hypertrophy and measure left ventricular ejection fraction, and Doppler echocardiography was used to estimate right ventricular systolic pressure. A 24-hour urine specimen was collected to measure creatinine clearance and, in a subset of patients, to assess urinary sodium excretion. Urine for microalbumin/creatinine ratio was determined in a random urine sample. Epworth sleepiness scale was used to determine subjective daytime sleepiness. 25 
Protocol
Polysomnography
Diagnostic overnight polysomnography was performed by personnel who were blinded to the BP status of the subjects using standard techniques and scoring of sleep stages and arousals. 26, 27 Thoracoabdominal movements and tidal volume were monitored by a respiratory inductance plethysmograph (Respitrace, Ambulatory Monitoring, Inc) and airflow by nasal pressure cannulae. 28 Oxyhemoglobin saturation (SaO 2 ) was continuously monitored by a pulse oximeter (Nellcor, N-200 pulse oximeter, Nellcor Inc) and recorded on a computerized sleep scoring system (Sandman, Nellcor Puritan Bennett Ltd). The mean and minimum SaO 2 s during sleep were recorded as described previously. 29 Apneas were defined as an absence of tidal volume for Ն10 seconds and were classified as obstructive if there was out-of-phase rib cage and abdominal motion and as central if there was no rib cage or abdominal motion. Hypopneas were defined as a Ͼ50% reduction in tidal volume but Ͼ0 for Ն10 seconds and were classified as "obstructive" if there was out-of-phase rib cage and abdominal motion or airflow limitation on the nasal pressure tracing and as "central" if there was in-phase rib cage and abdominal motion and no evidence of airflow limitation on the nasal pressure tracing. 2, 3 The frequency of apneas and hypopneas per hour of sleep was expressed as the AHI. Subjects who had an AHI Ն10 events per hour were classified as having sleep apnea and then further subclassified as either having OSA if Ն50% of the events were obstructive or having central sleep apnea if Ͼ50% of the events were central. 2, 3 
Assessments of Overnight Fluid Shift
Body weight was measured before being instrumented before going to bed and within 30 minutes of awakening the next morning before urinating. With subjects instrumented for sleep studies, lying awake and supine, total body water and leg fluid volume were measured using a bioelectrical impedance spectrum analyzer (model 4200, Xitron Technologies Inc) 30 with impedance to electric current being inversely proportional to fluid content. 31, 32 For total body water determination, electrodes were placed on the right wrist and ankle, whereas for leg fluid volume determination, electrodes were placed on the right upper thigh and ankle. The electrodes are imbedded in an adhesive-containing pad that is fixed to the skin. Electrodes were further secured to the skin with adhesive tape and left in place throughout the night. The circumference of the neck was measured just above the thyroid cartilage and of the right midcalf at its maximum girth with a tape measure. Lines were drawn at these levels with a marker pen to ensure that measurements after sleep were made at exactly the same levels as those before sleep. Within 15 minutes of awakening the next morning and before they had arisen, urinated, eaten, or drank, measurements of total body water, leg fluid volume, and neck and calf circumferences were repeated. Differences between measurements made after and before sleep were calculated as the overnight changes in these variables.
The human subjects review committee of the University of Toronto and the research ethics boards of Mount Sinai Hospital, University Health Network, and Toronto Rehabilitation Institute approved the protocol. All of the subjects provided written informed consent before participation.
Statistical Analysis
Continuous variables were expressed as meanϮSE and categorical variables as proportions. The CH and DRH groups were compared by unpaired t test, Wilcoxon rank-sum test, and Fisher exact test, as appropriate, and ANCOVA (with the preovernight value as a covariate) was also used to compare overnight fluid shift measurements in the 2 groups. The impact of several covariates (age, sex, race, BMI, diabetic status, body surface area-adjusted creatinine clearance, and left ventricular ejection fraction) were examined to ascertain whether they were associated with the overnight changes in leg fluid volume and whether they confounded the observed differences between the CH and DRH groups. In multivariate analyses that included creatinine clearance as a covariate, imputed values were used for missing data. Logistic regression was used to assign each subject a predicted probability of DRH (ie, a propensity score) based on age, sex, race, BMI, and diabetic status that was then entered as a single covariate in the between-group comparisons of the overnight leg fluid volume shifts.
Log-transformed values of the AHI, which provided the best fit for the data, were used to assess the relationship between the AHI and the overnight reduction in leg fluid volume. Because the relationship was log-linear, both least-squares regression and Poisson regression were used for modeling. Regression coefficients were calculated for the subjects with CH or DRH, and tests for interactions were performed to ascertain whether the coefficients differed according to BP status. A 2-tailed PϽ0.05 was considered statistically significant. All of the analyses were conducted using SAS version 9.1.3 (SAS Institute).
Results
Characteristics of the Subjects
The baseline characteristics of the 40 study subjects are summarized by group (DRH: nϭ25; CH: nϭ15) in Table 1 . By definition, subjects with DRH were on a greater number of antihypertensive drugs and had higher clinic and 24-hour BP values than subjects with CH (statistically significant for systolic BP and a trend for diastolic BP). More patients in the DRH group took more calcium channel blockers than the control group (96% versus 73%), and the majority of the patients (87%) were prescribed a dihydropyridine calcium channel blocker (1 patient took an agent from both classes). No patients took a central-acting sympatholytic agent. The DRH group had higher prevalences of diabetes mellitus and left ventricular hypertrophy, as well as higher urine sodium excretion, and as outlined in Table 2 , a higher AHI and arousal index and lower minimum SaO 2 %. Most respiratory events were obstructive in nature.
Overnight Fluid Shift Study Measurements
Before sleep, neck and calf circumferences were significantly greater in the DRH group than in the CH group, but there was no significant difference in leg fluid volume ( Table 2 ). The overnight reduction in body weight and total body water was similar in the DRH and CH groups (Table 3) . However, the overnight reduction in calf and increase in neck circumferences were significantly greater in the DRH group than in the CH group (Pϭ0.001 and 0.02, respectively). Moreover, the overnight reduction in leg fluid volume was also significantly greater in the DRH group than in the CH group (Pϭ0.0002), and the difference remained statistically significant after adjustment for age, sex, race, BMI, diabetic status, body surface area-adjusted creatinine clearance, and left ventricular ejection fraction (Pϭ0.006) or the propensity score (Pϭ0.01). There was no significant modification of the foregoing association between BP status and the overnight leg fluid volume reduction according to use of any of the antihypertensive drug classes (Pϭ0.30 [BP statusϫ antihypertensive drug class interaction term]). The minimum SaO 2 , but not mean SaO 2 , correlated inversely with the overnight reduction in leg fluid volume (R 2 ϭ0.13; Pϭ0.02). None of the covariates (ie, age, sex, race, BMI, diabetic status, body surface area-adjusted creatinine clearance, and left ventricular ejection fraction) was found to be associated with the degree of overnight leg fluid volume reduction.
The best correlate of the AHI was the overnight reduction in leg fluid volume (R 2 ϭ0.56; PϽ0.0001, using logtransformed values of AHI and least-square regression). The relationship, using untransformed values of the AHI, is exponential, as depicted in the Figure. By Poisson regression, there was a 58% increase in AHI per 100-mL reduction in leg fluid volume (95% CI: 38% to 84%; PϽ0.0001). There was also a weaker correlation between the overnight reduction in calf circumference and log-transformed AHI (R 2 ϭ0.19; Pϭ0.005). However, there was no significant relationship between the AHI and BMI, baseline neck circumference, or overnight increase in neck circumference.
Discussion
This study provides several new insights into the pathogenesis of OSA in patients with DRH. First, in the combined group of DRH and CH patients, we showed that the AHI, a measure of the severity of OSA, was strongly related to the amount of fluid displaced from the leg overnight. The change in leg fluid volume explained 56% of the variance in the log-transformed AHI. In contrast, there was no significant association between the AHI and BMI or baseline neck circumference, suggesting that body weight and central obesity are not as important as overnight rostral fluid displacement in the pathogenesis of OSA in hypertensive subjects. In both groups, neck circumference increased and calf circumference decreased, and the changes were greater in the DRH group. Accordingly, the higher AHI in the DRH than in the CH group may be at least partly attributable to the greater overnight fluid displacement from the leg and the greater overnight increase in neck circumference in DRH group but not to baseline differences in BMI or neck circumference. Such findings support the concept that redistribution of fluid into the neck and peripharyngeal tissue from the lower extremities during recumbency may account for the high prevalence of OSA in DRH.
Over the past several years, we have been evaluating the role of extracellular fluid movement centrally in the pathogenesis of OSA. Previously, we showed that application of lower body positive pressure by antishock trousers in healthy, nonobese subjects, while awake, causes a substantial fluid displacement from the legs to the neck and that this results in narrowing of the upper airway and an increase in its resistance to airflow, both of which should predispose to OSA during sleep. 18, 19, 33 Subsequently, we demonstrated in healthy, nonobese men that the amount of spontaneous fluid displacement out of the legs overnight was directly proportional to the overnight increase in neck circumference and to the severity of OSA as quantified by the AHI. 20 From these findings we formulated the concept that, with the assumption of the recumbent position before sleep at night, the transcapillary pressure gradient in the lower extremities falls as a result of the decrease in capillary pressure, which favors the movement of interstitial fluid into the intravascular space of the legs. The increase in intravascular volume redistributes into the upper body in relation to gravitational forces. Such rostral displacement of fluid causes an increase in central blood volume and capillary pressure in the neck tipping the balance of Starling's forces in favor of transudation of intravascular fluid into nuchal and peripharyngeal interstitial tissues, which compresses the upper airway and obstructs airflow.
There are many reasons to suspect that the associations are causal. The associations are strong, even after controlling for other known confounding factors, including age, sex, and BMI. In addition, the postulated mechanism by which leg fluid volume might reasonably be related to AHI has biological credibility and is supported by the results of other clinical studies. For example, peritoneal dialysis patients who were converted from nocturnal peritoneal dialysis to continuous ambulatory peritoneal dialysis had poorer fluid removal, higher AHI and greater reduction in pharyngeal volumes and cross-sectional area, and tongue enlargement, as assessed by volumetric MRI. 34 In addition, aggressive diuretic treatment in patients with severe OSA and diastolic heart failure significantly reduced AHI and increased oropharyngeal area, suggesting that pharyngeal edema contributed to upper airway collapse and severity of OSA during sleep. 35 Our results are also consistent with other investigations demonstrating increased risk of higher AHI with greater fluid displacement from the legs. 18 -20,33 Finally, there is a gradient of risk. We demonstrated that each 100-mL reduction in the overnight leg fluid volume was associated with a 1.58-fold increase in the AHI (Figure) and a 3.1% decrease in the minimum SaO 2 .
Because of the nature of the study design, observed associations, despite their strengths, can only infer causality. The possibility of residual confounding remains. All subjects had received instructions to reduce dietary sodium intake to the level recommended for hypertensive patients 36 ; still dietary sodium intake was greater in the DRH group (Table 1) . This might have contributed to a greater tendency to fluid retention and, as a consequence, to the greater overnight leg fluid volume reduction in the DRH group. Even so, overnight fluid displacement from the leg remained greater in the DRH group despite adjustment for the sodium excretion rate (Pϭ0.002). Although the literature on the effect of specific nondiuretic antihypertensive medications on OSA severity is limited and the influence is perhaps modest at most, 37 it remains possible that certain antihypertensive classes may be potential confounders. However, there was no significant interaction between BP status and antihypertensive drug class, including calcium channel blockers that can cause peripheral edema. The nature of the intercompartmental body fluid redistribution remains speculative given that bioelectrical impedance analysis cannot distinguish between intravascular and interstitial fluid. Finally, the change in leg fluid volume was measured using only the right leg; this of course assumes that the corresponding total leg fluid shift was twice that of the one leg.
Perspectives
The present study suggests that spontaneous rostral fluid displacement from the legs may be a unifying mechanism that explains, in part, increased tendency for the upper airway to collapse during sleep that applies both to otherwise healthy subjects 20 and to patients with either CH or DRH. As with otherwise healthy subjects, the spontaneous overnight leg fluid shift strongly related to the severity of OSA, as assessed by the AHI. In addition, the magnitude of fluid displacement was greater among DRH subjects and largely explained the higher AHI in this group than in the CH group. In view of the existing literature, such data strongly support the hypothesis that volume overload may be pathogenically related to the DRH state and, further, may contribute to the development or severity of OSA. However, to what degree such fluid excess is a consequence of these subjects' greater burden of hypertensive target organ damage (with reduced glomerular filtration rate and/or ventricular systolic/diastolic dysfunction) remains unknown. Nevertheless, our findings suggest the possibility that maneuvers to reduce extracellular fluid volume, such as diuretic therapy or a low-sodium diet, or to attenuate overnight rostral fluid shift, such as the use of support stockings or increased daytime activity, like walking, would reduce the severity of OSA and, by this means, lower BP. Further studies will be required to test these hypotheses.
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